Clinical Trials Directory

Trials / Completed

CompletedNCT02847143

Ocytocine and Cerebral Activation in Relation With Attachement

A Cross Over Randomized Controlled Trial of the Effect of Nasal Ocytocine on Cerebral Activations in Relation With Attachement in the General Population

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Centre Hospitalier Universitaire de Besancon · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The study aims to characterize the cerebral activation modifications related to nasal oxytocin administration during vizualisation of distress images in population of healthy people with different attachement styles.

Detailed description

Healthy adult male will be recruited. Their attachement style will be assessed through the Attachement scale interview (ASI). They will have 2 fMRI sessions, during which emotional images will be presented. One session will be preceded by a nasal administration of oxytocin and the other session will be preceded by a placebo nasal administration. The order of both administrations will be randomized.

Conditions

Interventions

TypeNameDescription
DRUGnasal oxytocin or placebonasal administration of oxytocin or palcebo 45 min befor fMRI session
DEVICEfMRIFMRI during emotional image visualization
BEHAVIORALAttachement scale interview (ASI)this scale is used to determine the attachement style of each participant
BEHAVIORALpsychometric scalesself adminstrated questionnaires which asses the level of anxiety (Spielberger State-trait anxiety interview-STAI), depression (Beck depression inventory-BDI) and alexithymia (Toronta Alexuthymia scale-TAS 20)

Timeline

Start date
2015-04-09
Primary completion
2018-04-27
Completion
2018-04-27
First posted
2016-07-28
Last updated
2024-10-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02847143. Inclusion in this directory is not an endorsement.